Recent studies suggest that dominant CMT mutations in glycyl-tRNA synthetase (GlyRS) activate the ISR by inducing ribosome stalling (40, 41, 42), and inhibiting the ISR alleviates peripheral neuropathy in a mouse model (40). Here, GARS1 is linked to peripheral neuropathy.